Interferon alfa-2c
- Generic Name
- Interferon alfa-2c
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 142192-09-4
- Unique Ingredient Identifier
- VW75A46X0K
- Background
Interferon alfa-2c is under investigation in clinical trial NCT00485563 (A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma).
- Associated Conditions
- -
- Associated Therapies
- -
Biochemotherapy With Temozolomide for Metastatic Melanoma
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-07-23
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00505635
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath